Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Rain Oncology Inc
Hoffmann-La Roche
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Novartis
Assistance Publique - Hôpitaux de Paris